[Skip to Content]
[Skip to Content Landing]
Article
June 1950

INTRAVENOUS ADMINISTRATION OF TETRACAINE (PONTOCAINE®) HYDROCHLORIDEPreliminary Report

Author Affiliations

MEMPHIS, TENN.

From the Department of Psychiatry and Neurology, College of Medicine, University of Tennessee.

Arch Intern Med (Chic). 1950;85(6):972-979. doi:10.1001/archinte.1950.00230120081008
Abstract

DURING the last eight years numerous reports have been published on the intravenous use of procaine (novocain®) hydrochloride. In the United States interest has centered mainly on administration in the slow intravenous drip of 0.1 and 0.2 per cent solutions, taking from twenty minutes to an hour and a half. Results have been excellent in the treatment of many traumatic conditions, inflammatory states and pain syndromes. Unfortunately, however, the giving of an infusion of 500 cc. of solution by slow intravenous drip is not practical in a physician's office. It seemed advisable to search for a more potent solution that could be given quickly in small doses. Workers in Europe have reported on the use of 1 per cent solution of procaine hydrochloride intravenously, with good results. It has been given in treatment of asthma,1 angina pectorislb and numerous other conditions, usually in doses of 3 to

First Page Preview View Large
First page PDF preview
First page PDF preview
×